Back
Lexaria Bioscience Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
14
LEXX
Lexaria Bioscience
Last Price:
2.07
Seasonality Move:
5.11%
Buy
79
AUPH
Aurinia Pharmaceuticals
Last Price:
8.88
Seasonality Move:
24.51%
Sell
14
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy, Sell or Hold?
- The current Lexaria Bioscience [LEXX] share price is $2.09. The Score for LEXX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- LEXX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
79
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.86. The Score for AUPH is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LEXX Stock Price Chart
What is Lexaria Bioscience's stock price today?
-
The Lexaria Bioscience share price today is $2.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing slight selling pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.
LEXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 34.82 | Sell |
Chaikin Money Flow: | -33987 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.11 - 2.55) | Sell |
Bollinger Bands (100): | (2.5 - 3.42) | Sell |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 72.92 | Buy |
Chaikin Money Flow: | 122744 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.17 - 8.37) | Buy |
Bollinger Bands (100): | (5.81 - 7.63) | Buy |
LEXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.14 | Sell |
20-day SMA: | 2.24 | Sell |
50-day SMA: | 2.71 | Sell |
200-day SMA: | 3.04 | Sell |
8-day EMA: | 2.16 | Sell |
20-day EMA: | 2.29 | Sell |
50-day EMA: | 2.59 | Sell |
200-day EMA: | 2.74 | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.34 | Buy |
20-day SMA: | 7.95 | Buy |
50-day SMA: | 7.43 | Buy |
200-day SMA: | 6.09 | Buy |
8-day EMA: | 8.41 | Buy |
20-day EMA: | 8.03 | Buy |
50-day EMA: | 7.49 | Buy |
200-day EMA: | 6.84 | Buy |
Lexaria Bioscience Earnings Growth & LEXX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Lexaria Bioscience Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |